i'd be amazed if the public were privy to that knockdown data at same time, rather than after, interested big pharma.
and i'd be equally amazed if big pharma aren't in close communication with benitec/tacere on this trial's progress. given it's a one shot cure for HCV it'd be very tardy of current HCV drug developers not to be watching this potential game changer very closely.
- Forums
- ASX - By Stock
- BLT
- what could happen if tt-034 is successful